Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Digital monitoring to prevent repeat strokes after a recent stroke

Official title: Medical Benefit of Digital Monitoring Using apTeleCare for Secondary Prevention in Patients With a Recent Transient Ischemic Attack or Stroke

Run by University Hospital, Bordeaux · NCT06837311 · Data updated 2026-11-12

This trial will test whether smartphone-based digital monitoring with biological and psychological checks helps people who recently had a stroke and currently smoke to stop smoking and lower their risk of another stroke.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment388 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Bordeaux)
StatusRecruiting
StartedMarch 25, 2025
Main results expectedMarch 25, 2027
Study endsMarch 25, 2028
Registry record updatedJuly 21, 2025
Trial IDNCT06837311 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–79 with a recent (≤15 days) symptomatic ischemic or hemorrhagic stroke or a high-risk TIA (ABCD2 ≥ 4) who smoke, can use a smartphone, live in an area with internet coverage, attend post-stroke follow-up at the neurovascular unit, and have French national health insurance.

Probably not a fit

Patients with severe cognitive impairment, severe aphasia or visual deficits that prevent participation, subarachnoid hemorrhage, non-smokers, those without smartphone/internet access, or people not eligible for French national health insurance are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults who recently experienced an ischemic or hemorrhagic stroke (or a high-risk TIA) and who smoke are enrolled during routine post-stroke follow-up at the neurovascular unit. Participants use smartphone ecological momentary assessment (EMA) to report behaviors and symptoms, undergo biological measures including expired carbon monoxide, and receive psychological and substance-use evaluations alongside standard care. The digital monitoring is intended to support behavior change and smoking cessation in the early post-stroke period. The program is delivered at CHU de Bordeaux and requires smartphone and internet access and French national health insurance.

Why it matters

Potential benefit: If successful, this approach could help recent stroke survivors who smoke quit sooner and reduce their risk of stroke recurrence and related disability.

How similar studies have gone: Digital and EMA-based interventions for smoking cessation and risk-factor monitoring have shown promising results in other populations, but applying them specifically to immediate post-stroke secondary prevention is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female
* At least 18 years of age and younger than 80 years;
* Recent (≤ 15 days) clinically symptomatic ischemic or hemorrhagic stroke documented through brain imaging (CT or MRI) or a Transient Ischemic Attack with an Predictive Risk Score (ABCD2) ≥ 4;
* Returning to the neurovascular unit for the standard care post-stroke follow-up visits;
* National Institute Health Stroke Scale (NIHSS) \< 15;
* modified Rankin scale ≤ 4;
* No severe cognitive impairment as defined by the neurologist;
* Current smokers (smoking at least 1 cigarette per day during the month before admission)
* Able to use a smartphone
* Living in an area with internet coverage
* Written informed consent by the patient;
* Coverage by the French National Health Insurance

Exclusion Criteria:

* Subarachnoid hemorrhage; Dementia syndrome or other central neurologic disorder;
* Severe aphasia (NIHSS item 9 ≥ 2)
* Severe visual impairment interfering with the completion of evaluations;
* Severely impaired physical and/or mental health that, according to the neurologist, may affect the participant's capacity to participate in the study;
* Individuals already undergoing treatment for tobacco cessation and/or SRADs at admission in the stroke unit;
* Pregnancy or breastfeeding;
* Inability to read French;
* Individuals under legal protection or unable to express personally their consent
* Participation in another protocol modifying the patient's follow-up status.
* Person deprived of liberty
* Person in emergency situation

Where it's running

  • CHU de Bordeaux
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.